Australasian Society for Bipolar Disorders Conference 2007

Session Details

Novel Treatments and Mechanisms in Bipolar Disorder

Friday, 21 September 2007 11:30 -12:30

Bayside Auditorium A

Chair Peter R Joyce University of OtagoNew Zealand

Glutathione Depletion in Animal Models of Psychiatric Disorders
  • Olivia M Dean, Mental Health Research Institute, Australia
  • The Glutathione Precursor N-acetyl Cysteine as a Treatment for Oxidative Stress in Bipolar Disorder: A Double Blind Randomised Placebo Controlled Trial
  • Michael Berk, University of Melbourne, Australia
  • Hormone Modulation - A Potential Treatment for Women in the Manic Phase of Bipolar Affective Disorder
  • Jayasrhi Kulkarni, Alfred Psychiatry Research Centre, Australia
  • Plasma Apolipoprotein E as a Potential Marker of Treatment Status in Bipolar Disorder
  • Suresh Sundram, Mental Health Research Institute of Victoria, Australia
  • Pathophysiology of Cognitive Impairment in Bipolar Disorders
  • Clarissa Gama, University of Melbourne, Australia
  • Published on Thursday, 20 September 2007 by the Professional Conference Organiser